Stocks and Investing Stocks and Investing
Mon, August 12, 2024

Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Increased Target to $18 on, Aug 12th, 2024


Published on 2024-10-28 13:33:10 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "ADMA Biologics, Inc." (ADMA) at Strong Buy with Increased Target from $10 to $18 on, Aug 12th, 2024.

Raghuram has made no other calls on ADMA in the last 4 months.



There are 3 other peers that have a rating on ADMA. Out of the 3 peers that are also analyzing ADMA, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Raghuram


  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $20 on, Friday, August 9th, 2024
  • Anthony Petrone of "Mizuho" Maintained at Strong Buy with Increased Target to $14 on, Thursday, June 20th, 2024
  • Elliot Wilbur of "Raymond James" Maintained at Strong Buy with Increased Target to $10 on, Friday, May 10th, 2024
Contributing Sources